This product, bioequivalent to Motegrity Tablets of Takeda Pharmaceuticals, will be manufactured at Lupin's Goa facility in India.

Lupin has about a dozen new products ready for export to the U.S. from the Goa facility, each worth about $20 million to $30 million in revenue, that have been delayed, Managing Director Nilesh ...

By Zeba Siddiqui GOA, India (Reuters) - In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. ... Lupin sets off down Indian pharma’s long road… Share this: ...

Lupin Ltd., India’s second-biggest drugmaker by market value, expects U.S. approvals for new products from its facility in the coastal state of Goa to begin again in the next two months as it ...

The Lupin shares crashed over 17% to trade at Rs 851 soon after it announced, in a stock filing, that it has received a warning letter issued by the USFDA pertaining to its plants located in Goa ...

New Delhi, Jul 21 (PTI) Drug firm Lupin today said its Goa plant has completed inspection by the US drug regulator without any observations. - Lupin's Goa facility completes USFDA inspection ...

* Lupin clarifies on news item, "Lupin's Goa plant receives adverse FDA observations". * Lupin clarifies that USFDA issued form 483 citing 3 observations Source text: Further company coverage ...

HYDERABAD: Pharmaceuticals firm Lupin Ltd on Monday said one of its plants in Goa may be subject to regulatory action by the US FDA. The Mumbai-based drug's maker added that the drugs controller ...

Just a fortnight earlier, Lupin received an approval from the US FDA to manufacture a generic drug, Meclizine Hydrochloride. These drugs are also being manufactured at Lupin’s facility in Goa.

Drug maker Lupin May 30 said the US health regulator has cautioned that the firm's Goa facility may be subject to regulatory or administrative action and it may withhold approval of any pending ...

April 3 (Reuters) - Lupin Ltd: April 3 (Reuters) - Lupin Ltd: Skip to main content. Exclusive news, data and analytics for financial market professionals Learn more about Refinitiv. World.

GOA, India (Reuters) - In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier. Most of the last six months on his desk calendar is marked green, indicating visits to the ...